» Articles » PMID: 15009436

Expression of Matrix Metalloproteinases and Their Inhibitors During the Resorption of Schistosome Egg-induced Fibrosis in Praziquantel-treated Mice

Overview
Journal Immunology
Date 2004 Mar 11
PMID 15009436
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Schistosomiasis mansoni is a tropical helminthic disease characterized by parasite egg-induced granulomatous inflammation and cumulative fibrosis. Because fibrosis is influenced by the imbalance between degradative matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), we analysed the resorption of fibrous tissue and MMP/TIMP expression in the livers of S. mansoni-infected and praziquantel-cured mice. Worm elimination significantly enhanced survival rate, ameliorated the granulomatous pathology and reduced collagen I, III and IV gene expression at 6 and 12 months post-treatment. Compared to 6 months infected, untreated controls, liver fibrous tissue was resorbed by 71.4% at 12 months after treatment. At 3 months post-treatment, expression of the MMP-2, -3, -8, -10, -13, -14 and -16 genes decreased compared with untreated controls. By 6 months, a highly significant increase in MMP-10 gene expression was manifest. At 12 months, messages for all MMP genes decreased in relation to untreated controls. TIMP-1, -2 and -3 gene expression drastically decreased between 3 and 6 months. At 1 year, only TIMP-1 expression was significantly diminished. Overall, profibrogenic tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and inducible nitric oxide synthase (iNOS) gene expression decreased. Antigen-stimulated splenocytes secreted significantly higher levels of interleukin (IL)-4, IL-5, IL-10 and IL-13 cytokines between 3 and 12 months after treatment. Production of interferon (IFN)-gamma was higher than in untreated controls 3 and 6 months after treatment. In conclusion, praziquantel-treated mice showed a slow resorption of liver fibrous tissue. Resorption is attributed to the precipitous drop in TIMP-1 gene expression level, which shifted the balance in favour of MMP message expression and presumed enhanced collagenase activity.

Citing Articles

New tricks for old drugs- praziquantel ameliorates bleomycin-induced pulmonary fibrosis in mice.

Zeng Y, Hu R, Ma W, Ding Y, Zhou Y, Peng X BMC Pharmacol Toxicol. 2024; 25(1):18.

PMID: 38355586 PMC: 10868045. DOI: 10.1186/s40360-024-00737-7.


The Role of Praziquantel in the Prevention and Treatment of Fibrosis Associated with Schistosomiasis: A Review.

Niu X, Hu T, Hong Y, Li X, Shen Y J Trop Med. 2022; 2022:1413711.

PMID: 36313856 PMC: 9616668. DOI: 10.1155/2022/1413711.


The Role of Tissue Inhibitor of Metalloproteinase-1 and 2 in Echinococcus granulosus senso lato-Induced Human Hepatic Fibrosis.

Hasanzadeh A, Rafiei A, Kazemi M, Beiromvand M, Bahreini A, Khanahmad H Acta Parasitol. 2022; 67(2):851-857.

PMID: 35294975 DOI: 10.1007/s11686-022-00534-4.


Praziquantel ameliorates CCl -induced liver fibrosis in mice by inhibiting TGF-β/Smad signalling via up-regulating Smad7 in hepatic stellate cells.

Liu J, Kong D, Qiu J, Xie Y, Lu Z, Zhou C Br J Pharmacol. 2019; 176(24):4666-4680.

PMID: 31412137 PMC: 6965681. DOI: 10.1111/bph.14831.


Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.

Almeer R, El-Khadragy M, Abdelhabib S, Abdel Moneim A PLoS One. 2018; 13(10):e0204923.

PMID: 30273397 PMC: 6166951. DOI: 10.1371/journal.pone.0204923.


References
1.
Fallon P, Richardson E, McKenzie G, McKenzie A . Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol. 2000; 164(5):2585-91. DOI: 10.4049/jimmunol.164.5.2585. View

2.
Vaillant B, Chiaramonte M, CHEEVER A, Soloway P, Wynn T . Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol. 2001; 167(12):7017-26. DOI: 10.4049/jimmunol.167.12.7017. View

3.
Hesse M, CHEEVER A, Jankovic D, Wynn T . NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease. Am J Pathol. 2000; 157(3):945-55. PMC: 1885696. DOI: 10.1016/S0002-9440(10)64607-X. View

4.
Bica I, Hamer D, Stadecker M . Hepatic schistosomiasis. Infect Dis Clin North Am. 2000; 14(3):583-604, viii. DOI: 10.1016/s0891-5520(05)70122-7. View

5.
McCrudden R, Iredale J . Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. Histol Histopathol. 2000; 15(4):1159-68. DOI: 10.14670/HH-15.1159. View